Quick Answer
Niagen Bioscience, Inc. reported Net Income Loss of $17.38 million for the year ending 2025.
- Niagen Bioscience, Inc. showed an increase of +103.3% in Net Income Loss from 2024 to 2025.
- This data is from Niagen Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: -$989.7 thousand | Q3 2013: -$1.25 million | Q4 2013: -$724.3 thousand | Q1 2014: -$1.85 million | Q2 2014: -$1.65 million | Q3 2014: -$659.7 thousand | Q4 2014: -$1.23 million | Q1 2015: -$1.03 million | Q2 2015: -$315.2 thousand | Q3 2015: -$3.7 thousand | Q4 2015: -$1.43 million | Q1 2016: $255.6 thousand | Q2 2016: -$82.7 thousand | Q3 2016: -$954.4 thousand | Q4 2016: -$2.15 million | Q1 2017: -$1.93 million | Q2 2017: -$2.76 million | Q3 2017: $2.14 million | Q4 2017: -$8.82 million | Q1 2018: -$8.44 million | Q2 2018: -$8.05 million | Q3 2018: -$8.61 million | Q1 2019: -$8.34 million | Q2 2019: -$7.76 million | Q3 2019: -$7.20 million | Q1 2020: -$5.90 million | Q2 2020: -$3.71 million | Q3 2020: -$4.22 million | Q1 2021: -$7.38 million | Q2 2021: -$5.57 million | Q3 2021: -$8.86 million | Q1 2022: -$7.74 million | Q2 2022: -$6.40 million | Q3 2022: -$985.0 thousand | Q1 2023: -$1.90 million | Q2 2023: -$2.19 million | Q3 2023: -$959.0 thousand | Q1 2024: -$492.0 thousand | Q2 2024: -$15.0 thousand | Q3 2024: $1.88 million | Q1 2025: $5.06 million | Q2 2025: $3.61 million | Q3 2025: $4.58 million.
- Over the full 16 years of available data (2010 to 2025), Niagen Bioscience, Inc.'s Net Income Loss has grown by 947.2%.
- Historical annual values: Fiscal year 2025: $17.38 million | Fiscal year 2024: $8.55 million | Fiscal year 2023: -$4.94 million | Fiscal year 2022: -$16.54 million | Fiscal year 2021: -$27.13 million | Fiscal year 2020: -$19.93 million | Fiscal year 2019: -$32.15 million | Fiscal year 2018: -$33.32 million | Fiscal year 2017: -$11.38 million | Fiscal year 2016: -$2.93 million | Fiscal year 2015: -$2.77 million | Fiscal year 2014: -$5.39 million | Fiscal year 2013: -$4.42 million | Fiscal year 2012: -$11.66 million | Fiscal year 2011: -$7.89 million | Fiscal year 2010: -$2.05 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: